Delcath Systems Inc (DCTH)
Healthcare
Medical Devices
12.20 $
+1.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Delcath Systems Inc (DCTH)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 82.8% of the shares are freely tradable; institutional investors hold 48.9%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
48.9%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
8.1%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
82.8%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
10.4%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
35Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | 9.56 | 3,300,389 | +0.0 | 03/31/2026 |
| BlackRock Inc | 5.17 | 1,784,466 | -2.2 | 03/31/2026 |
| Vanguard Group Inc | 4.84 | 1,672,357 | +0.9 | 12/31/2025 |
| Vanguard Capital Management, LLC | 3.85 | 1,329,288 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 2.00 | 692,031 | +1.3 | 03/31/2026 |
| State Street Corp | 1.92 | 664,428 | +9.3 | 03/31/2026 |
| Private Wealth Advisors, LLC | 1.71 | 591,524 | +103.6 | 03/31/2026 |
| Millennium Management LLC | 1.70 | 588,055 | +138.6 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.85 | 983,010 | +0.0 | 04/30/2026 |
| iShares Russell 2000 ETF | 2.13 | 735,328 | +0.9 | 05/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.